Drugs Made In America Acquisition II Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to search for business combination targets in the pharmaceutical industry. The Company is neither engaged in any operations nor generated any revenues.
公司代碼DMII
公司Drugs Made In America Acquisition II Ord Shs
CEOStockwell (Lynn)
網址
常見問題
Drugs Made In America Acquisition II Ord Shs(DMII)的當前股價是多少?
Drugs Made In America Acquisition II Ord Shs(DMII)的當前股價是 9.880。
Drugs Made In America Acquisition II Ord Shs 的股票代碼是什麼?
Drugs Made In America Acquisition II Ord Shs的股票代碼是DMII。
Drugs Made In America Acquisition II Ord Shs股票的52週最高點是多少?
Drugs Made In America Acquisition II Ord Shs股票的52週最高點是9.890。
Drugs Made In America Acquisition II Ord Shs股票的52週最低點是多少?
Drugs Made In America Acquisition II Ord Shs股票的52週最低點是9.860。
Drugs Made In America Acquisition II Ord Shs的市值是多少?
Drugs Made In America Acquisition II Ord Shs的市值是--。
Drugs Made In America Acquisition II Ord Shs的淨利潤是多少?
Drugs Made In America Acquisition II Ord Shs的淨利潤為--。
現在Drugs Made In America Acquisition II Ord Shs(DMII)的股票是買入、持有還是賣出?
根據分析師評級,Drugs Made In America Acquisition II Ord Shs(DMII)的總體評級為--,目標價格為--。
Drugs Made In America Acquisition II Ord Shs(DMII)股票的每股收益(EPS TTM)是多少
Drugs Made In America Acquisition II Ord Shs(DMII)股票的每股收益(EPS TTM)是--。